Administration of Allogenic UC-MSCs as Adjuvant Therapy for Critically-Ill COVID-19 Patients
Clinical trial NCT04457609 · UNKNOWN
Trial details
- NCT number
- NCT04457609
- Sponsor
- Indonesia University
- Status
- UNKNOWN
- Phase
- Phase 1
- Study type
- INTERVENTIONAL
- Start date
- 2020-07-01
- Primary completion
- 2020-08-01
- Enrollment
- 40
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.